Chapter/Section Purchase

1 Study Coverage
1.1 HER2 Antibody Revenue in HER2 Antibody Business (2017-2022) & (US$ Million) Introduction
1.2 Global HER2 Antibody Outlook 2017 VS 2022 VS 2028
1.2.1 Global HER2 Antibody Market Size for the Year 2017-2028
1.2.2 Global HER2 Antibody Market Size for the Year 2017-2028
1.3 HER2 Antibody Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States HER2 Antibody in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of HER2 Antibody Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 HER2 Antibody Market Dynamics
1.4.1 HER2 Antibody Industry Trends
1.4.2 HER2 Antibody Market Drivers
1.4.3 HER2 Antibody Market Challenges
1.4.4 HER2 Antibody Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 HER2 Antibody by Type
2.1 HER2 Antibody Market Segment by Type
2.1.1 Trastuzumab
2.1.2 Lapatinib
2.1.3 Ado-trastuzumab Emtansine
2.1.4 Pertuzumab
2.1.5 Everolimus
2.2 Global HER2 Antibody Market Size by Type (2017, 2022 & 2028)
2.3 Global HER2 Antibody Market Size by Type (2017-2028)
2.4 United States HER2 Antibody Market Size by Type (2017, 2022 & 2028)
2.5 United States HER2 Antibody Market Size by Type (2017-2028)
3 HER2 Antibody by Application
3.1 HER2 Antibody Market Segment by Application
3.1.1 Hospital
3.1.2 Medical Center
3.2 Global HER2 Antibody Market Size by Application (2017, 2022 & 2028)
3.3 Global HER2 Antibody Market Size by Application (2017-2028)
3.4 United States HER2 Antibody Market Size by Application (2017, 2022 & 2028)
3.5 United States HER2 Antibody Market Size by Application (2017-2028)
4 Global HER2 Antibody Competitor Landscape by Company
4.1 Global HER2 Antibody Market Size by Company
4.1.1 Top Global HER2 Antibody Companies Ranked by Revenue (2021)
4.1.2 Global HER2 Antibody Revenue by Player (2017-2022)
4.2 Global HER2 Antibody Concentration Ratio (CR)
4.2.1 HER2 Antibody Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of HER2 Antibody in 2021
4.2.3 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global HER2 Antibody Headquarters, Revenue in HER2 Antibody Business (2017-2022) & (US$ Million) Type
4.3.1 Global HER2 Antibody Headquarters and Area Served
4.3.2 Global HER2 Antibody Companies Revenue in HER2 Antibody Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into HER2 Antibody Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States HER2 Antibody Market Size by Company
4.5.1 Top HER2 Antibody Players in United States, Ranked by Revenue (2021)
4.5.2 United States HER2 Antibody Revenue by Players (2020, 2021 & 2022)
5 Global HER2 Antibody Market Size by Region
5.1 Global HER2 Antibody Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global HER2 Antibody Market Size by Region (2017-2028)
5.2.1 Global HER2 Antibody Market Size by Region: 2017-2022
5.2.2 Global HER2 Antibody Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America HER2 Antibody Market Size YoY Growth 2017-2028
6.1.2 North America HER2 Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific HER2 Antibody Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific HER2 Antibody Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe HER2 Antibody Market Size YoY Growth 2017-2028
6.3.2 Europe HER2 Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America HER2 Antibody Market Size YoY Growth 2017-2028
6.4.2 Latin America HER2 Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa HER2 Antibody Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa HER2 Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Genentech Inc
7.1.1 Genentech Inc Company Details
7.1.2 Genentech Inc Business Overview
7.1.3 Genentech Inc HER2 Antibody Introduction
7.1.4 Genentech Inc Revenue in HER2 Antibody Business (2017-2022)
7.1.5 Genentech Inc Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Company Details
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG HER2 Antibody Introduction
7.2.4 Novartis AG Revenue in HER2 Antibody Business (2017-2022)
7.2.5 Novartis AG Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer HER2 Antibody Introduction
7.3.4 Pfizer Revenue in HER2 Antibody Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Abnova Corporation
7.4.1 Abnova Corporation Company Details
7.4.2 Abnova Corporation Business Overview
7.4.3 Abnova Corporation HER2 Antibody Introduction
7.4.4 Abnova Corporation Revenue in HER2 Antibody Business (2017-2022)
7.4.5 Abnova Corporation Recent Development
7.5 InvivoGen
7.5.1 InvivoGen Company Details
7.5.2 InvivoGen Business Overview
7.5.3 InvivoGen HER2 Antibody Introduction
7.5.4 InvivoGen Revenue in HER2 Antibody Business (2017-2022)
7.5.5 InvivoGen Recent Development
7.6 Celltrion
7.6.1 Celltrion Company Details
7.6.2 Celltrion Business Overview
7.6.3 Celltrion HER2 Antibody Introduction
7.6.4 Celltrion Revenue in HER2 Antibody Business (2017-2022)
7.6.5 Celltrion Recent Development
7.7 Biocon Limited
7.7.1 Biocon Limited Company Details
7.7.2 Biocon Limited Business Overview
7.7.3 Biocon Limited HER2 Antibody Introduction
7.7.4 Biocon Limited Revenue in HER2 Antibody Business (2017-2022)
7.7.5 Biocon Limited Recent Development
7.8 Bio-Techne
7.8.1 Bio-Techne Company Details
7.8.2 Bio-Techne Business Overview
7.8.3 Bio-Techne HER2 Antibody Introduction
7.8.4 Bio-Techne Revenue in HER2 Antibody Business (2017-2022)
7.8.5 Bio-Techne Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer